464 results on '"Varlet, Pascale"'
Search Results
2. Specific brain MRI features of constitutional mismatch repair deficiency syndrome in children with high-grade gliomas
3. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
4. Imaging features to distinguish posterior fossa ependymoma subgroups
5. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation
6. PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumors
7. Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
8. Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling
9. CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm
10. A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma
11. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population
12. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature
13. Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion
14. NF2 and ZFTA evaluation in the diagnostic algorithm of pediatric posterior fossa ependymoma with H3K27ME3 retained expression
15. Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
16. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities
17. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
18. All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant
19. Apports et limites de la FISH dans le diagnostic des tumeurs du système nerveux central selon la classification de l’OMS de 2021 : retour d’expérience du service de neuropathologie de l’hôpital Sainte-Anne
20. Can novel CT-and MR-based neuroimaging biomarkers further improve the etiological diagnosis of lobar intra-cerebral hemorrhage?
21. Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours
22. An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive
23. Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as “Glioneuronal Tumors, NOS, Subtype A”
24. Ré-utilisation de lames d’immunohistochimie pour la réalisation de FISH : une solution pertinente d’épargne tissulaire
25. Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile
26. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
27. A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused
28. The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients
29. Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas
30. Cerebral amyloid angiopathy-related acute lobar intra-cerebral hemorrhage: diagnostic value of plain CT
31. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions
32. The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profile
33. Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis
34. Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
35. A non-midline unclassified glioneuronal tumor with H3K27M mutation enlarging the spectrum of CNS tumors H3K27ME3-altered.
36. Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features
37. A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion
38. Radiographic growth rate as a predictor of aggressiveness of diffuse gliomas without 1p19q codeletion
39. Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma
40. Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered.
41. Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology.
42. Correction to: Can novel CT-and MR-based neuroimaging biomarkers further improve the etiological diagnosis of lobar intra-cerebral hemorrhage?
43. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric‐ and adult‐type gliomas
44. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions
45. LEF-1 immunohistochemistry, a better diagnostic biomarker than β-catenin for medulloblastoma, WNT-activated subtyping
46. “Hemispheric pilocytic astrocytoma” revisited: A comprehensive clinicopathological and molecular series emphasizing their overlap with other glioneuronal tumors
47. BRAIN METASTASIS OF A UROTHELIAL NEUROENDOCRINE CARCINOMA: A DOUBLE PITFALL FOR NEUROPATHOLOGISTS AND DNA‐METHYLATION PROFILING
48. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation
49. Table S4 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
50. Supplementary Figures 1-15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.